C-Rad AB (publ) (CRAD-B.ST)
SEK 29.9
(-0.17%)
SEK 29.9
(-0.17%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 66.01 Million SEK | -67.85% |
| 2022 | 205.3 Million SEK | 20.6% |
| 2021 | 170.22 Million SEK | 24.35% |
| 2020 | 136.89 Million SEK | 7.15% |
| 2019 | 127.75 Million SEK | 12.51% |
| 2018 | 113.55 Million SEK | 36.84% |
| 2017 | 82.98 Million SEK | 65.18% |
| 2016 | 50.23 Million SEK | 31.02% |
| 2015 | 38.34 Million SEK | 8.43% |
| 2014 | 35.36 Million SEK | 20.33% |
| 2013 | 29.38 Million SEK | 96.92% |
| 2012 | 14.92 Million SEK | 17.57% |
| 2011 | 12.69 Million SEK | -17.31% |
| 2010 | 15.35 Million SEK | 62.8% |
| 2009 | 9.42 Million SEK | -2.13% |
| 2008 | 9.63 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 20.4 Million SEK | 51.11% |
| 2024 Q3 | 72.7 Million SEK | -0.49% |
| 2024 Q1 | 13.5 Million SEK | -56.17% |
| 2023 Q1 | 59 Million SEK | -21.02% |
| 2023 FY | 66 Million SEK | -67.85% |
| 2023 Q4 | 30.8 Million SEK | -59.58% |
| 2023 Q2 | 59.7 Million SEK | 1.19% |
| 2023 Q3 | 76.2 Million SEK | 27.64% |
| 2022 Q3 | 53.8 Million SEK | 32.19% |
| 2022 Q1 | 36.1 Million SEK | -34.99% |
| 2022 Q2 | 40.7 Million SEK | 12.74% |
| 2022 FY | 205.3 Million SEK | 20.6% |
| 2022 Q4 | 74.7 Million SEK | 38.85% |
| 2021 Q3 | 40.3 Million SEK | 6.33% |
| 2021 FY | 170.22 Million SEK | 24.35% |
| 2021 Q2 | 37.9 Million SEK | 0.8% |
| 2021 Q1 | 37.6 Million SEK | -15.3% |
| 2021 Q4 | 55.52 Million SEK | 37.79% |
| 2020 FY | 136.89 Million SEK | 7.15% |
| 2020 Q3 | 33 Million SEK | 19.57% |
| 2020 Q2 | 27.6 Million SEK | -13.48% |
| 2020 Q1 | 31.9 Million SEK | -5.22% |
| 2020 Q4 | 44.39 Million SEK | 34.52% |
| 2019 Q1 | 28.7 Million SEK | -19.05% |
| 2019 Q2 | 30.9 Million SEK | 7.67% |
| 2019 Q3 | 34.5 Million SEK | 11.65% |
| 2019 FY | 127.75 Million SEK | 12.51% |
| 2019 Q4 | 33.65 Million SEK | -2.45% |
| 2018 Q4 | 35.45 Million SEK | 20.59% |
| 2018 Q2 | 28.1 Million SEK | 36.41% |
| 2018 FY | 113.55 Million SEK | 36.84% |
| 2018 Q1 | 20.6 Million SEK | -22.5% |
| 2018 Q3 | 29.4 Million SEK | 4.63% |
| 2017 Q3 | 20.6 Million SEK | 5.71% |
| 2017 Q1 | 16.41 Million SEK | -6.69% |
| 2017 FY | 82.98 Million SEK | 65.18% |
| 2017 Q4 | 26.58 Million SEK | 29.03% |
| 2017 Q2 | 19.48 Million SEK | 18.74% |
| 2016 Q3 | 12.67 Million SEK | 36.02% |
| 2016 Q4 | 17.58 Million SEK | 38.77% |
| 2016 FY | 50.23 Million SEK | 31.02% |
| 2016 Q1 | 9.94 Million SEK | -11.89% |
| 2016 Q2 | 9.31 Million SEK | -6.28% |
| 2015 Q1 | 9.79 Million SEK | -9.14% |
| 2015 FY | 38.34 Million SEK | 8.43% |
| 2015 Q4 | 11.28 Million SEK | 57.33% |
| 2015 Q3 | 7.17 Million SEK | -28.94% |
| 2015 Q2 | 10.09 Million SEK | 3.06% |
| 2014 Q1 | 9.13 Million SEK | -22.19% |
| 2014 Q3 | 6.85 Million SEK | -20.26% |
| 2014 FY | 35.36 Million SEK | 20.33% |
| 2014 Q4 | 10.77 Million SEK | 57.32% |
| 2014 Q2 | 8.59 Million SEK | -5.98% |
| 2013 FY | 29.38 Million SEK | 96.92% |
| 2013 Q1 | 4.89 Million SEK | -34.01% |
| 2013 Q2 | 3.78 Million SEK | -22.7% |
| 2013 Q3 | 8.97 Million SEK | 137.3% |
| 2013 Q4 | 11.74 Million SEK | 30.94% |
| 2012 Q1 | 902 Thousand SEK | -69.3% |
| 2012 FY | 14.92 Million SEK | 17.57% |
| 2012 Q4 | 7.41 Million SEK | 142.8% |
| 2012 Q3 | 3.05 Million SEK | -16.18% |
| 2012 Q2 | 3.64 Million SEK | 303.66% |
| 2011 Q1 | 3.73 Million SEK | 5.06% |
| 2011 Q4 | 2.93 Million SEK | -28.05% |
| 2011 Q2 | 1.94 Million SEK | -48.03% |
| 2011 Q3 | 4.08 Million SEK | 110.46% |
| 2011 FY | 12.69 Million SEK | -17.31% |
| 2010 Q2 | 3.28 Million SEK | -20.42% |
| 2010 Q3 | 4.37 Million SEK | 32.99% |
| 2010 Q1 | 4.13 Million SEK | 18.63% |
| 2010 FY | 15.35 Million SEK | 62.8% |
| 2010 Q4 | 3.55 Million SEK | -18.77% |
| 2009 Q3 | 151 Thousand SEK | -94.18% |
| 2009 Q2 | 2.59 Million SEK | -18.88% |
| 2009 Q1 | 3.19 Million SEK | 76.71% |
| 2009 FY | 9.42 Million SEK | -2.13% |
| 2009 Q4 | 3.48 Million SEK | 2207.3% |
| 2008 FY | 9.63 Million SEK | 0.0% |
| 2008 Q2 | 3.09 Million SEK | 42.41% |
| 2008 Q1 | 2.17 Million SEK | 0.0% |
| 2008 Q3 | 2.45 Million SEK | -20.87% |
| 2008 Q4 | 1.81 Million SEK | -26.11% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acarix AB (publ) | 5.29 Million SEK | -1146.271% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 78.039% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 78.039% |
| Arcoma AB | 11.07 Million SEK | -496.288% |
| Bactiguard Holding AB (publ) | 139.98 Million SEK | 52.84% |
| BICO Group AB (publ) | 1.83 Billion SEK | 96.394% |
| Boule Diagnostics AB (publ) | 249.71 Million SEK | 73.564% |
| CellaVision AB (publ) | 463.04 Million SEK | 85.743% |
| Clinical Laserthermia Systems AB (publ) | 2.99 Million SEK | -2102.703% |
| Chordate Medical Holding AB (publ) | -28.41 Million SEK | 332.332% |
| Duearity AB (publ) | -4.17 Million SEK | 1680.062% |
| Dignitana AB (publ) | 58.97 Million SEK | -11.945% |
| Episurf Medical AB (publ) | -41.8 Million SEK | 257.931% |
| Getinge AB (publ) | 13.43 Billion SEK | 99.508% |
| Scandinavian Real Heart AB (Publ) | -50.21 Million SEK | 231.459% |
| Iconovo AB (publ) | 17.57 Million SEK | -275.562% |
| Integrum AB (publ) | 690.56 Thousand SEK | -9459.605% |
| Luxbright AB (publ) | -2.79 Million SEK | 2460.312% |
| Mentice AB (publ) | 236.38 Million SEK | 72.073% |
| OssDsign AB (publ) | 83.64 Million SEK | 21.077% |
| Paxman AB (publ) | 12.61 Million SEK | -423.181% |
| Promimic AB (publ) | 38.51 Million SEK | -71.401% |
| Qlife Holding AB (publ) | -50.75 Million SEK | 230.071% |
| SciBase Holding AB (publ) | 16.03 Million SEK | -311.642% |
| ScandiDos AB (publ) | 47.55 Million SEK | -38.818% |
| Sectra AB (publ) | 557.55 Million SEK | 88.16% |
| Sedana Medical AB (publ) | 108.98 Million SEK | 39.425% |
| Senzime AB (publ) | 8.33 Million SEK | -691.642% |
| SpectraCure AB (publ) | -9.22 Million SEK | 815.765% |
| Stille AB | 132.17 Million SEK | 50.053% |
| Vitrolife AB (publ) | 1.97 Billion SEK | 96.663% |
| Xvivo Perfusion AB (publ) | 416.91 Million SEK | 84.166% |